Learn More
AIMS The optimal neoadjuvant therapy option for locally advanced oesophageal cancer remains elusive. Neoadjuvant chemoradiotherapy (CRT) is the preferred modality of choice in the USA. In contrast,(More)
Sir d Temozolomide has an excellent safety profile; however, very rarely, profound myelosuppression and aplastic anaemia after a limited exposure to temozolomide have been reported in a few reviews(More)